Application 208446
- Type
- ANDA
- Sponsor
- MYLAN
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | ABIRATERONE ACETATE | ABIRATERONE ACETATE | TABLET;ORAL | 250MG | No | No |
| 002 | ABIRATERONE ACETATE | ABIRATERONE ACETATE | TABLET;ORAL | 500MG | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A208446-001 | ABIRATERONE ACETATE | ABIRATERONE ACETATE | 250MG | TABLET / ORAL | AB | 2018-10-31 | |
| A208446-002 | ABIRATERONE ACETATE | ABIRATERONE ACETATE | 500MG | TABLET / ORAL | AB | 2020-12-14 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A208446-001 | AB |
| A208446-002 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A208446-001 | ABIRATERONE ACETATE | 250MG | TABLET / ORAL | AB | 2018-10-31 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A208446-002 | ABIRATERONE ACETATE | 500MG | TABLET / ORAL | AB | 2020-12-14 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A208446-001 | AB | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A208446-002 | AB | 1 | a50c72e98297… |
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Abiraterone Acetate | ABIRATERONE ACETATE | Mylan Pharmaceuticals Inc. | fe02db79-fa04-441f-b514-70bd74af6624 | 2026-04-15 | Warnings, Adverse reactions | 208446 ANDA208446 0378-6920 0378-6921 |
| Abiraterone Acetate | ABIRATERONE ACETATE | Bryant Ranch Prepack | 79082b18-adde-4ffb-832a-b8c1d030c413 | 2023-12-07 | Warnings, Adverse reactions | 208446 ANDA208446 |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 0378-6920 | Abiraterone Acetate | abiraterone acetate | Mylan Pharmaceuticals Inc. | ANDA | Current |
| 0378-6920 | Abiraterone Acetate | abiraterone acetate | Mylan Pharmaceuticals Inc. | ANDA | Current |
| 0378-6920 | Abiraterone Acetate | abiraterone acetate | Mylan Pharmaceuticals Inc. | ANDA | Current |
| 0378-6920 | Abiraterone Acetate | abiraterone acetate | Mylan Pharmaceuticals Inc. | ANDA | Current |
| 0378-6920 | Abiraterone Acetate | abiraterone acetate | Mylan Pharmaceuticals Inc. | ANDA | Current |
| 0378-6920 | Abiraterone Acetate | abiraterone acetate | Mylan Pharmaceuticals Inc. | ANDA | Current |
| 0378-6920 | Abiraterone Acetate | abiraterone acetate | Mylan Pharmaceuticals Inc. | ANDA | Current |
| 0378-6921 | Abiraterone Acetate | abiraterone acetate | Mylan Pharmaceuticals Inc. | ANDA | Current |
| 0378-6921 | Abiraterone Acetate | abiraterone acetate | Mylan Pharmaceuticals Inc. | ANDA | Current |
| 0378-6921 | Abiraterone Acetate | abiraterone acetate | Mylan Pharmaceuticals Inc. | ANDA | Current |
| 0378-6921 | Abiraterone Acetate | abiraterone acetate | Mylan Pharmaceuticals Inc. | ANDA | Current |
| 0378-6924 | Abiraterone Acetate | abiraterone acetate | Mylan Pharmaceuticals Inc. | ANDA | Current |
| 0378-6924 | Abiraterone Acetate | abiraterone acetate | Mylan Pharmaceuticals Inc. | ANDA | Current |
| 0378-6924 | Abiraterone Acetate | abiraterone acetate | Mylan Pharmaceuticals Inc. | ANDA | Current |
| 0378-6924 | Abiraterone Acetate | abiraterone acetate | Mylan Pharmaceuticals Inc. | ANDA | Current |
| 0378-6924 | Abiraterone Acetate | abiraterone acetate | Mylan Pharmaceuticals Inc. | ANDA | Current |
| 42292-057 | Abiraterone Acetate | abiraterone acetate | Mylan Institutional Inc. | ANDA | Current |
| 42292-057 | Abiraterone Acetate | abiraterone acetate | Mylan Institutional Inc. | ANDA | Current |
| 51407-181 | Abiraterone Acetate | abiraterone acetate | Golden State Medical Supply Inc. | ANDA | Current |
| 51407-181 | Abiraterone Acetate | abiraterone acetate | Golden State Medical Supply, Inc. | ANDA | Current |
| 51407-181 | Abiraterone Acetate | abiraterone acetate | Golden State Medical Supply, Inc. | ANDA | Current |
| 51407-181 | Abiraterone Acetate | abiraterone acetate | Golden State Medical Supply, Inc. | ANDA | Current |
| 51407-181 | Abiraterone Acetate | abiraterone acetate | Golden State Medical Supply, Inc. | ANDA | Current |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 56234 | ORIG | 2018-11-01 |